Healthcare Finance News November 24, 2021
Rising supply chain challenges are a headwind to revenue, but the issues may begin to subside in mid-2022, a Fitch Ratings report says.
Labor shortages and supply chain challenges are a rising threat to profit margins for U.S. healthcare and pharmaceutical companies, according to a new report from Fitch Ratings.
The scarcity of workers is likely to increase pressure on some issuers’ margins in the near term but is unlikely to trigger any credit downgrades, the report added.
Multiple factors are contributing to labor pressures, including staff burnouts caused by the enduring COVID-19 pandemic and an overall shortage of qualified help, which has resulted in higher costs to hire temporary staff, as well as wage inflation.
Furthermore, the report noted...